The R code used to perform the fits of the data is provided (R 4

The R code used to perform the fits of the data is provided. (R 4 KB) References 1. Bigger JW: Treatment of staphylococcal infections with Tideglusib penicillin – by intermittent sterilisation. Lancet 1944, 2:497–500.CrossRef 2. del Pozo JL, Patel R: The challenge of treating biofilm-associated bacterial infection. Clin Pharmacol Ther 2007,82(2): 204–209.PubMedCrossRef 3. Lewis K: Persister cells. Annu Rev Microbiol 2010, 64:357–372.PubMedCrossRef 4. Mulcahy LR, Burns JL, Lory S, Lewis K: Emergence of pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol 2010,192(23): 6191–6199.PubMedCrossRef

5. Tuomanen E, Cozens R, Tosch W, Zak O, Tomasz A: The rate of killing of escherichia-coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial-growth. J Gen Microbiol 1986, 132:1297–1304.PubMed 6. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S: Bacterial persistence as a phenotypic switch. Science 2004,305(5690): 1622–1625.PubMedCrossRef 7. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K: Specialized persister cells and the mechanism of multidrug selleck inhibitor tolerance in escherichia coli. J Bacteriol

2004,186(24): 8172–8180.PubMedCrossRef 8. Shah D, Zhang ZG, Khodursky A, Kaldalu N, Kurg K, Lewis K: Persisters: a distinct physiological state of E-coli. BMC Microbiology 2006, 6:53.PubMedCrossRef 9. Lewis K: Persister cells, dormancy and infectious disease. Nat Rev Microbiol 2007,5(1): 48–56.PubMedCrossRef PLX-4720 in vivo 10. Dorr T, Lewis K, Vulic M: SOS response induces persistence to fluoroquinolones in escherichia coli. PLoS Genet 2009,5(12): e1000760.PubMedCrossRef 11. Maisonneuve E, Shakespeare LJ, Jorgensen MG, Gerdes K: Bacterial persistence learn more by RNA endonucleases. P Natl Acad Sci USA 2011,108(32): 13206–13211.CrossRef 12. Moyed HS, Bertrand KP: Hipa, a newly

recognized gene of escherichia-coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol 1983,155(2): 768–775.PubMed 13. Korch SB, Hill TM: Ectopic overexpression of wild-type and mutant hipA genes in escherichia coli: effects on macromolecular synthesis and persister formation. J Bacteriol 2006,188(11): 3826–3836.PubMedCrossRef 14. Dhar N, McKinney JD: Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice. P Natl Acad Sci USA 2010,107(27): 12275–12280.CrossRef 15. Singh R, Barry CE, Boshoff HIM: The three RelE homologs of mycobacterium tuberculosis have individual, drug-specific effects on bacterial antibiotic tolerance. J Bacteriol 2010,192(5): 1279–1291.PubMedCrossRef 16. Keren I, Minami S, Rubin E, Lewis K: Characterization and transcriptome analysis of mycobacterium tuberculosis persisters. Mbio 2011,2(3): e00100–11.PubMedCrossRef 17. Belenky P, Collins JJ: Antioxidant strategies to tolerate antibiotics. Science 2011,334(6058): 915–916.PubMedCrossRef 18. Stewart B, Rozen DE: Genetic variation for antibiotic persistence in escherichia coli.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>